BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $426,839 | -27.0% | 11,310 | +65.8% | 0.11% | -26.5% |
| Q4 2021 | $585,000 | +22.9% | 6,822 | +15.3% | 0.15% | +13.1% |
| Q3 2021 | $476,000 | +2.6% | 5,917 | +2.6% | 0.13% | 0.0% |
| Q2 2021 | $464,000 | -10.3% | 5,767 | -5.9% | 0.13% | -15.0% |
| Q1 2021 | $517,000 | +9.3% | 6,127 | +3.9% | 0.15% | +2.7% |
| Q4 2020 | $473,000 | -0.2% | 5,897 | 0.0% | 0.15% | -14.9% |
| Q3 2020 | $474,000 | -6.5% | 5,897 | 0.0% | 0.18% | -9.3% |
| Q2 2020 | $507,000 | +5.8% | 5,897 | -0.1% | 0.19% | +18.4% |
| Q1 2020 | $479,000 | +3.7% | 5,902 | +6.9% | 0.16% | +35.8% |
| Q4 2019 | $462,000 | -4.0% | 5,522 | +0.4% | 0.12% | -13.7% |
| Q3 2019 | $481,000 | +5.0% | 5,502 | -1.5% | 0.14% | -11.5% |
| Q2 2019 | $458,000 | -1.5% | 5,587 | -2.3% | 0.16% | -0.6% |
| Q1 2019 | $465,000 | +23.7% | 5,717 | +0.2% | 0.16% | +10.5% |
| Q4 2018 | $376,000 | -5.8% | 5,705 | +10.3% | 0.14% | +5.1% |
| Q3 2018 | $399,000 | +4.7% | 5,170 | +0.3% | 0.14% | 0.0% |
| Q2 2018 | $381,000 | +14.1% | 5,155 | +0.3% | 0.14% | +3.8% |
| Q1 2018 | $334,000 | +11.0% | 5,140 | +10.4% | 0.13% | +12.0% |
| Q4 2017 | $301,000 | +8.3% | 4,655 | +5.1% | 0.12% | +2.6% |
| Q3 2017 | $278,000 | +11.2% | 4,430 | -8.0% | 0.11% | +1.8% |
| Q1 2017 | $250,000 | +17.4% | 4,815 | +0.1% | 0.11% | +12.0% |
| Q4 2016 | $213,000 | -7.0% | 4,810 | +0.1% | 0.10% | -7.4% |
| Q3 2016 | $229,000 | +2.2% | 4,805 | -3.0% | 0.11% | -2.7% |
| Q2 2016 | $224,000 | +46.4% | 4,955 | +6.6% | 0.11% | +46.1% |
| Q3 2015 | $153,000 | -49.7% | 4,650 | +6.9% | 0.08% | -47.6% |
| Q2 2015 | $304,000 | +4.8% | 4,350 | +2.9% | 0.14% | +6.6% |
| Q1 2015 | $290,000 | -5.5% | 4,229 | +0.9% | 0.14% | -3.5% |
| Q4 2014 | $307,000 | +4.4% | 4,190 | +2.2% | 0.14% | -2.8% |
| Q3 2014 | $294,000 | -0.7% | 4,100 | 0.0% | 0.14% | -1.4% |
| Q2 2014 | $296,000 | -2.0% | 4,100 | 0.0% | 0.15% | -1.3% |
| Q1 2014 | $302,000 | +118.8% | 4,100 | +95.2% | 0.15% | +93.5% |
| Q3 2013 | $138,000 | -16.9% | 2,100 | -12.5% | 0.08% | -22.2% |
| Q2 2013 | $166,000 | – | 2,400 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |